242 related articles for article (PubMed ID: 18157138)
41. Low-level expression of functional foamy virus receptor on hematopoietic progenitor cells.
von Laer D; Lindemann D; Roscher S; Herwig U; Friel J; Herchenröder O
Virology; 2001 Sep; 288(1):139-44. PubMed ID: 11543666
[TBL] [Abstract][Full Text] [Related]
42. Sustained transgene expression by human cord blood derived CD34+ cells transduced with simian immunodeficiency virus agmTYO1-based vectors carrying the human coagulation factor VIII gene in NOD/SCID mice.
Kikuchi J; Mimuro J; Ogata K; Tabata T; Ueda Y; Ishiwata A; Kimura K; Takano K; Madoiwa S; Mizukami H; Hanazono Y; Kume A; Hasegawa M; Ozawa K; Sakata Y
J Gene Med; 2004 Oct; 6(10):1049-60. PubMed ID: 15386735
[TBL] [Abstract][Full Text] [Related]
43. Insulated Foamy Viral Vectors.
Browning DL; Collins CP; Hocum JD; Leap DJ; Rae DT; Trobridge GD
Hum Gene Ther; 2016 Mar; 27(3):255-66. PubMed ID: 26715244
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells.
Braun SE; Wong FE; Connole M; Qiu G; Lee L; Gillis J; Lu X; Humeau L; Slepushkin V; Binder GK; Dropulic B; Johnson RP
Mol Ther; 2005 Dec; 12(6):1157-67. PubMed ID: 16168713
[TBL] [Abstract][Full Text] [Related]
45. Foamy virus vectors for gene transfer.
Trobridge GD
Expert Opin Biol Ther; 2009 Nov; 9(11):1427-36. PubMed ID: 19743892
[TBL] [Abstract][Full Text] [Related]
46. Improved gene transfer into canine hematopoietic repopulating cells using CD34-enriched marrow cells in combination with a gibbon ape leukemia virus-pseudotype retroviral vector.
Kiem HP; McSweeney PA; Bruno B; Goerner M; Buron G; Morris J; Storb R; Miller AD
Gene Ther; 1999 Jun; 6(6):966-72. PubMed ID: 10455398
[TBL] [Abstract][Full Text] [Related]
47. Comparison of three retroviral vector systems for transduction of nonobese diabetic/severe combined immunodeficiency mice repopulating human CD34+ cord blood cells.
Leurs C; Jansen M; Pollok KE; Heinkelein M; Schmidt M; Wissler M; Lindemann D; Von Kalle C; Rethwilm A; Williams DA; Hanenberg H
Hum Gene Ther; 2003 Apr; 14(6):509-19. PubMed ID: 12718762
[TBL] [Abstract][Full Text] [Related]
48. Transduction of long-term and mobilized peripheral blood-derived NOD/SCID repopulating cells by foamy virus vectors.
Josephson NC; Trobridge G; Russell DW
Hum Gene Ther; 2004 Jan; 15(1):87-92. PubMed ID: 14965380
[TBL] [Abstract][Full Text] [Related]
49. Transduction of human hematopoietic stem cells by lentiviral vectors pseudotyped with the RD114-TR chimeric envelope glycoprotein.
Di Nunzio F; Piovani B; Cosset FL; Mavilio F; Stornaiuolo A
Hum Gene Ther; 2007 Sep; 18(9):811-20. PubMed ID: 17824830
[TBL] [Abstract][Full Text] [Related]
50. Cell-cycle dependence of foamy virus vectors.
Patton GS; Erlwein O; McClure MO
J Gen Virol; 2004 Oct; 85(Pt 10):2925-2930. PubMed ID: 15448354
[TBL] [Abstract][Full Text] [Related]
51. Foamy virus vectors expressing anti-HIV transgenes efficiently block HIV-1 replication.
Taylor JA; Vojtech L; Bahner I; Kohn DB; Laer DV; Russell DW; Richard RE
Mol Ther; 2008 Jan; 16(1):46-51. PubMed ID: 17955023
[TBL] [Abstract][Full Text] [Related]
52. Gene therapy for canine alpha-L-iduronidase deficiency: in utero adoptive transfer of genetically corrected hematopoietic progenitors results in engraftment but not amelioration of disease.
Lutzko C; Omori F; Abrams-Ogg AC; Shull R; Li L; Lau K; Ruedy C; Nanji S; Gartley C; Dobson H; Foster R; Kruth S; Dubé ID
Hum Gene Ther; 1999 Jun; 10(9):1521-32. PubMed ID: 10395377
[TBL] [Abstract][Full Text] [Related]
53. Comparative analysis of FV vectors with human α- or β-globin gene regulatory elements for the correction of β-thalassemia.
Morianos I; Siapati EK; Pongas G; Vassilopoulos G
Gene Ther; 2012 Mar; 19(3):303-11. PubMed ID: 21734726
[TBL] [Abstract][Full Text] [Related]
54. Lentivirus and foamy virus vectors: novel gene therapy tools.
Pandya S; Klimatcheva E; Planelles V
Expert Opin Biol Ther; 2001 Jan; 1(1):17-40. PubMed ID: 11727544
[TBL] [Abstract][Full Text] [Related]
55. Feline foamy virus-based vectors: advantages of an authentic animal model.
Liu W; Lei J; Liu Y; Lukic DS; Räthe AM; Bao Q; Kehl T; Bleiholder A; Hechler T; Löchelt M
Viruses; 2013 Jul; 5(7):1702-18. PubMed ID: 23857307
[TBL] [Abstract][Full Text] [Related]
56. Detection of the causal mutation for canine leukocyte adhesion deficiency (CLAD) using pyrosequencing.
Kijas JM; Juneja RK; Gäfvert S; Andersson L
Anim Genet; 2000 Oct; 31(5):326-8. PubMed ID: 11105214
[TBL] [Abstract][Full Text] [Related]
57. A foamy virus vector system for stable and efficient RNAi expression in mammalian cells.
Papadaki M; Siapati EK; Vassilopoulos G
Hum Gene Ther; 2011 Oct; 22(10):1293-303. PubMed ID: 21456885
[TBL] [Abstract][Full Text] [Related]
58. Expression from second-generation feline immunodeficiency virus vectors is impaired in human hematopoietic cells.
Price MA; Case SS; Carbonaro DA; Yu XJ; Petersen D; Sabo KM; Curran MA; Engel BC; Margarian H; Abkowitz JL; Nolan GP; Kohn DB; Crooks GM
Mol Ther; 2002 Nov; 6(5):645-52. PubMed ID: 12409263
[TBL] [Abstract][Full Text] [Related]
59. Canine models of gene-modified hematopoiesis.
Beard BC; Kiem HP
Methods Mol Biol; 2009; 506():341-61. PubMed ID: 19110637
[TBL] [Abstract][Full Text] [Related]
60. Production of foamy virus vector and transduction of hematopoietic cells.
Josephson NC; Russell DW
Cold Spring Harb Protoc; 2010 Sep; 2010(9):pdb.prot5481. PubMed ID: 20810629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]